Hanna Soini's research while affiliated with U. S. Department of Homeland Security and other places

Publications (3)

Article
Full-text available
Background Tuberculosis (TB) is a major cause of death in HIV patients worldwide. Here we describe the epidemiology and outcome of HIV-TB co-infections in a high-income country with low TB incidence and integrated HIV and TB therapy according to European guidelines. Methods This study was based on the HIV cohort of the Helsinki University Hospital...
Article
Background: Epidemiological data on childhood nontuberculous mycobacterial (NTM) disease is scarce and the protective effect of Bacillus Calmette-Guérin (BCG) vaccination remains debated. In 2006 the BCG policy in Finland changed from universal to selective. We aimed to study the effect of the BCG coverage decrease on the incidence of childhood NT...
Article
Full-text available
Background We investigated the epidemiology and prevalence of potential risk factors of tuberculosis (TB) recurrence in a population-based registry cohort of 8084 TB cases between 1995 and 2013. Methods An episode of recurrent TB was defined as a case re-registered in the National Infectious Disease Register at least 360 days from the date of the i...

Citations

... HIV care in Finland is free of charge, and patients can initiate ART upon diagnosis. There have been clinical studies of physical health outcomes among HIV patients in Finland and of HIV epidemiology in the country (e.g., Holmberg et al., 2019). However, social sciences empirical research into the experience of living with HIV in low prevalence countries, such as Finland, has been lacking. ...
... Other studies have also suggested an increase in the prevalence rates of NTM over the last four decades (29). Previous studies indicated that Bacille Calmette-Guérin (BCG) vaccination confers cross-protection against NTM, thus in countries without a nationwide BCG immunization program, a rise in NTM cases is expected (30)(31)(32)(33). However, BCG is compulsory for all newborns in China since 1978, and BCG coverage in Zhejiang Province in 2017 was more than 90% (34). ...
... A WHO report estimated that 6.8% of TB cases recurred worldwide in 2019 [11], and recurrence occurs not only in high TB incidence countries, but also in low countries [12][13][14]. A retrospective study of surveillance data and clinical records in Finland showed 0.6% of TB cases were recurrent from 1995 to 2013 [15], and 1.3% of TB cases were recurrent in Barcelona from 2003 to 2006 [12], and the proportion of recurrent cases between 4.2 and 5.7% in the United States during 1993-2010 [16]. In addition, 5.3% of successfully treated bacteriologically confirmed cases had a recurrence in Shanghai [5], China, and 6.8% in Beijing [6]. ...